Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Consensus Rating of “Hold” by Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Rating) have been given an average recommendation of “Hold” by the eleven ratings firms that are currently covering the stock, reports. Three investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $8,650.00.

Several equities research analysts have issued reports on RBGLY shares. Jefferies Financial Group lowered Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a research note on Wednesday, March 23rd. Royal Bank of Canada raised Reckitt Benckiser Group from a “sector perform” rating to an “outperform” rating in a research note on Wednesday, May 18th. Exane BNP Paribas raised Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Monday, March 14th. Barclays boosted their target price on Reckitt Benckiser Group from GBX 9,100 ($110.45) to GBX 9,300 ($112.88) in a research note on Tuesday, May 3rd. Finally, Sanford C. Bernstein lowered Reckitt Benckiser Group from a “market perform” rating to an “underperform” rating in a research note on Monday, March 14th.

Shares of RBGLY stock opened at $14.90 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.62 and a debt-to-equity ratio of 0.95. The business has a 50-day moving average price of $15.74 and a two-hundred day moving average price of $16.22. Reckitt Benckiser Group has a 12-month low of $14.40 and a 12-month high of $18.78.

The firm also recently declared a dividend, which was paid on Thursday, June 16th. Investors of record on Friday, April 29th were issued a dividend of $0.2432 per share. The ex-dividend date was Thursday, April 28th. This represents a yield of 2.63%.

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Want More Great Investing Ideas?

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.